Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

NCT01520350 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped recruitment issues

Conditions

Bipolar Disorder
Depressive Episode

Interventions

DRUG: Low dose Adjunctive Aripiprazole
DRUG: placebo

Sponsor

Serge Beaulieu

Collaborators

[object Object]